Recombinant PDPK1 anticorps
Aperçu rapide pour Recombinant PDPK1 anticorps (ABIN7090704)
Antigène
Voir toutes PDPK1 AnticorpsType d'anticorp
Reactivité
Hôte
Clonalité
Conjugué
Application
-
-
Fonction
- PDPK1 Recombinant Antibody
-
Réactivité croisée
- Humain
-
Homologie
- Mouse
-
Purification
- Purified by Protein A.
-
Immunogène
- KLH conjugated synthetic peptide derived from human PDPK1
-
Isotype
- IgG
-
-
-
-
Indications d'application
- IHC-P(IHC-P=1:200-500), IHC-F(ICC=1:50), IF(IF=1:50-100), ICC/IF(1:50-100)
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- Lot specific
-
Buffer
- 0.01M TBS ( pH 7.4), 1 % BSA, 0.02 % Proclin 300, and 50 % Glycerol
-
Agent conservateur
- ProClin
-
Précaution d'utilisation
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Stock
- 4 °C,-20 °C
-
Stockage commentaire
- Shipped at 4C. Store at -20C for one year. Avoid repeated freeze/thaw cycles.
-
Date de péremption
- 12 months
-
-
- PDPK1 (3-phosphoinositide Dependent Protein Kinase-1 (PDPK1))
-
Autre désignation
- PDPK1
-
Sujet
-
Synonyms: 3 Phosphoinositide Dependent Protein Kinase 1, hPDK 1, hPDK 1, PDK 1, PkB kinase, PkB kinase like gene 1, PkB like 1, PDPK1_HUMAN.
Background: Enables 3-phosphoinositide-dependent protein kinase activity, phospholipase activator activity, and phospholipase binding activity. Involved in several processes, including cell surface receptor signaling pathway, regulation of protein kinase activity, and regulation of signal transduction. Acts upstream of or within intracellular signal transduction. Located in cell projection, cytosol, and plasma membrane. Implicated in prostate cancer. Biomarker of lung non-small cell carcinoma. [provided by Alliance of Genome Resources, Nov 2021]
-
ID gène
- 5170
-
UniProt
- O15530
-
Pathways
- Signalisation PI3K-Akt, TCR Signaling, Fc-epsilon Receptor Signaling Pathway, EGFR Signaling Pathway, Neurotrophin Signaling Pathway, Regulation of Leukocyte Mediated Immunity, Positive Regulation of Immune Effector Process, Cell-Cell Junction Organization, Regulation of Cell Size, Skeletal Muscle Fiber Development, CXCR4-mediated Signaling Events, Signaling Events mediated by VEGFR1 and VEGFR2, VEGFR1 Specific Signals
Antigène
-